Outcomes of Rapid Treatment With Sofosbuvir-Velpatasvir in Patients With Hepatitis C Virus who use Injectable Drugs Madison Heck, MPH, CHESThe following article is a part of conference coverage from the IDWeek 2021, being held virtually from September 29 to October 3, 2021. The team at Infectious Disease Advisor will be reporting on the latest news and research conducted by leading experts in the field. Check back for more from the IDWeek 2021.Among patients with hepatitis C virus (HCV) infection with a history of injectable drug use, those who underwent rapid treatment with a 7-day course [...]
https://www.hepatitiscmsg.org/....blog/outcomes-of-rap